Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study.

Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study. Biol Psychiatry. 1995 Dec 01; 38(11):765-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.